Supplementary Methods and Tables. Table S1. S100A16 expression and clinicopathological variables of the OSCC patients. Table S2. Details of the TaqMan assays used for qRT-PCR. Table S3. Details of the antibodies used for immunoblotting. (DOCX 31 kb
Demographics for TCGA HNSCC Progressors. Table S2. Demographics for TCGA HNSCC Non-progressors. (DOC...
Annotation for seven CpG sites selected by SIS. Table S2 Cox regression analysis of clinical charact...
Table S1. Clinical characteristics. Table S2. RNA-seq gene function list. Table S3. Gene function an...
Positive correlation between S100A16 mRNA expression and differentiation markers in OSCC specimens. ...
(A) S100A16 staining was strong with membranous localization at the invading front/island of well-di...
Down-regulation of S100A16 mRNA levels in tumor tissues as compared to the normal controls in indepe...
Table S1. Primers used for qPCR analysis in this study. Table S2. Quantitative proteomic analysis of...
Table S1. Data description of TCGA RNA sequencing data. Table S2. List of antibody-drug conjugates. ...
Table S1 List of proteins present in CTB-, AV-EVs and crude plasma of non-responders HNSCC patients....
Clinicopathological characteristics of cancer patients used in this study. Table S1. All primer pair...
Table S1. Characteristics of R/M HNSCC patients treated with cetuximab-based therapy. (DOCX 19 kb
Figure S1. Correlation of CYR61 expression of CRC tissues in IHC and clinicopathological parameters....
Table S1. Primer and probe sequences used for qPCR assay for the detection of CTC in blood obtained ...
Table S2 List of proteins present in CTB-, AV-EVs and crude plasma of complete responders HNSCC pati...
Detailed information of tumoral characteristics of patients and the information of metastasis. *The ...
Demographics for TCGA HNSCC Progressors. Table S2. Demographics for TCGA HNSCC Non-progressors. (DOC...
Annotation for seven CpG sites selected by SIS. Table S2 Cox regression analysis of clinical charact...
Table S1. Clinical characteristics. Table S2. RNA-seq gene function list. Table S3. Gene function an...
Positive correlation between S100A16 mRNA expression and differentiation markers in OSCC specimens. ...
(A) S100A16 staining was strong with membranous localization at the invading front/island of well-di...
Down-regulation of S100A16 mRNA levels in tumor tissues as compared to the normal controls in indepe...
Table S1. Primers used for qPCR analysis in this study. Table S2. Quantitative proteomic analysis of...
Table S1. Data description of TCGA RNA sequencing data. Table S2. List of antibody-drug conjugates. ...
Table S1 List of proteins present in CTB-, AV-EVs and crude plasma of non-responders HNSCC patients....
Clinicopathological characteristics of cancer patients used in this study. Table S1. All primer pair...
Table S1. Characteristics of R/M HNSCC patients treated with cetuximab-based therapy. (DOCX 19 kb
Figure S1. Correlation of CYR61 expression of CRC tissues in IHC and clinicopathological parameters....
Table S1. Primer and probe sequences used for qPCR assay for the detection of CTC in blood obtained ...
Table S2 List of proteins present in CTB-, AV-EVs and crude plasma of complete responders HNSCC pati...
Detailed information of tumoral characteristics of patients and the information of metastasis. *The ...
Demographics for TCGA HNSCC Progressors. Table S2. Demographics for TCGA HNSCC Non-progressors. (DOC...
Annotation for seven CpG sites selected by SIS. Table S2 Cox regression analysis of clinical charact...
Table S1. Clinical characteristics. Table S2. RNA-seq gene function list. Table S3. Gene function an...